About Amyris
Amyris is a company based in Emeryville (United States) founded in 2003. Amyris has raised $487.2 million across 61 funding rounds from investors including SAS, Kleiner Perkins and dsm-firmenich. The company has 747 employees as of December 31, 2022. Amyris has completed 8 acquisitions, including Beauty Labs, Costa Brazil and Draths Corporation. Amyris offers products and services including Sustainable Ingredients and Squalene. Amyris operates in a competitive market with competitors including Syngenta, AskBio, Ginkgo Bioworks, Twist Bioscience and Antheia, among others.
- Headquarter Emeryville, United States
- Employees 747 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amyris, Inc.
-
Annual Revenue
$269.85 M (USD)-21as on Dec 31, 2022
-
Net Profit
-$528.51 M (USD)-95as on Dec 31, 2022
-
EBITDA
-$568.98 M (USD)-220as on Dec 31, 2022
-
Total Equity Funding
$487.2 M (USD)
in 61 rounds
-
Latest Funding Round
Not available
-
Investors
SAS
& 18 more
-
Employee Count
747
as on Dec 31, 2022
-
Investments & Acquisitions
Beauty Labs
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amyris
Amyris offers a comprehensive portfolio of products and services, including Sustainable Ingredients and Squalene.
Bioidentical molecules for skincare and vaccines via fermentation
Sustainable alternative for vaccine adjuvants and cosmetics
People of Amyris
Unlock access to complete
Unlock access to complete
Software Development Team
42 people
Leadership Team
24 people
Product Management Team
17 people
Senior Team
12 people
Sales and Marketing
10 people
Human Resources and Administration
8 people
Data Analysis and Operations Team
7 people
Process Team
7 people
Unlock access to complete
Funding Insights of Amyris
Amyris has successfully raised a total of $487.2M across 61 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amyris
Amyris has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include SAS, Kleiner Perkins and dsm-firmenich.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Capital is provided to support biomedical industry innovations.
|
Locked | Locked | Locked | |
|
Venture capital and private equity firm
|
Locked | Locked | Locked |
Investor details for Amyris
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amyris
Amyris has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Beauty Labs, Costa Brazil and Draths Corporation.
Investment portfolio details for Amyris
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Probiotic supplements for menopause symptoms are developed.
|
Locked | Locked | 2019 | Locked | |
|
Natural skincare products are offered through an internet-first brand.
|
Locked | Locked | 2017 | Locked | |
|
Influencer marketing, content marketing, and branding services are provided.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Amyris
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Amyris
Detailed financials for Amyris
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amyris Comparisons
Peer comparison for Amyris
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amyris
Amyris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngenta, AskBio, Ginkgo Bioworks, Twist Bioscience and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of Amyris
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amyris
Complete news archive for Amyris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amyris
Amyris was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Amyris is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Amyris is a funded company, having raised a total of $487.2M across 61 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Amyris is 747.
Annual revenue of Amyris is $269.85M as on Dec 31, 2022.
Amyris was founded in 2003 and is headquartered in Emeryville, United States. Renewable products are developed for various industrial applications, with a focus on consumer materials, polymers, biofuels, and lubricants. Efforts are also directed toward semi-synthetic artemisinin as a treatment for malaria. Operations center on biotechnology and sustainable chemistry within the renewables sector.
Amyris offers Sustainable Ingredients and Squalene.
Amyris has made 8 acquisitions, including Beauty Labs, Costa Brazil, and Draths Corporation.
Amyris has 19 investors. Key investors include SAS, Kleiner Perkins, dsm-firmenich, Khosla Ventures, and TPG.